NAGE

Niagen Bioscience

83 hedge funds and large institutions have $75.8M invested in Niagen Bioscience in 2021 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 29 increasing their positions, 21 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more call options, than puts

Call options by funds: $ | Put options by funds: $

more funds holding in top 10

Funds holding in top 10:

less ownership

Funds ownership:

3% less funds holding

Funds holding: 8683 (-3)

13% less first-time investments, than exits

New positions opened: 13 | Existing positions closed: 15

41% less capital invested

Capital invested by funds: $129M → $75.8M (-$53.2M)

Holders
83
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$185K
Puts
$154K
Net Calls
Net Calls Change

Top Buyers

1 +$433K
2 +$420K
3 +$349K
4
Goldman Sachs
Goldman Sachs
New York
+$295K
5
Millennium Management
Millennium Management
New York
+$272K

Top Sellers

1 -$4.27M
2 -$675K
3 -$557K
4
Vanguard Group
Vanguard Group
Pennsylvania
-$339K
5
Group One Trading
Group One Trading
Illinois
-$210K
Name Holding Trade Value Shares
Change
Change in
Stake
26
$232K
27
$228K
28
$206K
29
$194K
30
$190K
31
$174K
32
$168K
33
$145K
34
$142K
35
$133K
36
$110K
37
$110K
38
$105K
39
$100K
40
$95K
41
$94K
42
$93K
43
$91K
44
$90K
45
$85K
46
$79K
47
$79K
48
$78K
49
$76K
50
$72K